{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:30:42Z","timestamp":1792589442485,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.vaccine.2024.06.057","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T21:01:20Z","timestamp":1720818080000},"page":"126090","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Short- and long-term outcomes of cardiac adverse events following COVID-19 immunization managed in a Canadian pediatric center"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5728-3134","authenticated-orcid":false,"given":"Anne","family":"Pham-Huy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Bowes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Amira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5786-4993","authenticated-orcid":false,"given":"Lillian","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.06.057_b0005","unstructured":"Edouard Mathieu, Hannah Ritchie, Lucas Rod\u00e9s-Guirao, Cameron Appel, Charlie Giattino, Joe Hasell, Bobbie Macdonald, Saloni Dattani, Diana Beltekian, Esteban Ortiz-Ospina and Max RoserEdouard Mathieu, Hannah Ritchie, Lucas Rod\u00e9s-Guirao, Cameron Appel, Char EO-O and MR. Coronavirus (COVID-19) Vaccinations. Our World in Data. https:\/\/ourworldindata.org\/covid-vaccinations. Published 2020. Accessed February 21, 2024."},{"key":"10.1016\/j.vaccine.2024.06.057_b0010","first-page":"1","article-title":"Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel","author":"Mevorach","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.06.057_b0015","doi-asserted-by":"crossref","unstructured":"Gargano JW, Wallace M, Hadler SC, et al. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices \u2014 United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021;70(27). doi:10.15585\/mmwr.mm7027e2.","DOI":"10.15585\/mmwr.mm7027e2"},{"issue":"12","key":"10.1016\/j.vaccine.2024.06.057_b0020","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s40264-020-01002-6","article-title":"Assessing the Safety of COVID-19 Vaccines: a Primer","volume":"43","author":"Petousis-Harris","year":"2020","journal-title":"Drug Saf"},{"issue":"29","key":"10.1016\/j.vaccine.2024.06.057_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2021.05.087","article-title":"Myocarditis following COVID-19 mRNA vaccination","volume":"39","author":"Abu Mouch","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.06.057_b0030","first-page":"1","article-title":"Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review","author":"Pillay","year":"2022","journal-title":"BMJ"},{"issue":"14","key":"10.1016\/j.vaccine.2024.06.057_b0035","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jama.2021.15072","article-title":"Surveillance for adverse events after COVID-19 mRNA vaccination","volume":"326","author":"Klein","year":"2021","journal-title":"JAMA - J Am Med Assoc"},{"issue":"4","key":"10.1016\/j.vaccine.2024.06.057_b0040","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2318","article-title":"Cardiac complications following mRNA COVID-19 vaccines: a systematic review of case reports and case series","volume":"32","author":"Fazlollahi","year":"2022","journal-title":"Rev Med Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2024.06.057_b0045","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1001\/jamacardio.2021.3471","article-title":"Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children","volume":"6","author":"Dionne","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.vaccine.2024.06.057_b0050","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-057508","article-title":"Risk of Myopericarditis After COVID-19 Vaccination in Danish Children Aged 5 to 11 Years","volume":"150","author":"Nygaard","year":"2022","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2024.06.057_b0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.vaccine.2022.10.079","article-title":"Reactions following Pfizer-BioNTech COVID-19 mRNA vaccination and related healthcare encounters among 7,077 children aged 5\u201311 years within an integrated healthcare system","volume":"41","author":"Malden","year":"2023","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2024.06.057_b0060","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S2213-2600(22)00059-5","article-title":"Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis","volume":"10","author":"Ling","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"22","key":"10.1016\/j.vaccine.2024.06.057_b0065","article-title":"Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA : a follow-up surveillance study","volume":"4642","author":"Kracalik","year":"2022","journal-title":"Lancet Child Adolesc Heal"},{"issue":"10","key":"10.1016\/j.vaccine.2024.06.057_b0070","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.vaccine.2021.11.074","article-title":"Myocarditis and pericarditis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"40","author":"Sexson Tejtel","year":"2022","journal-title":"Vaccine"},{"issue":"42","key":"10.1016\/j.vaccine.2024.06.057_b0075","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","article-title":"2015 ESC Guidelines for the diagnosis and management of pericardial diseases","volume":"36","author":"Adler","year":"2015","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.vaccine.2024.06.057_b0080","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/jama.2021.13443","article-title":"Myocarditis and Pericarditis after Vaccination for COVID-19","volume":"326","author":"Diaz","year":"2021","journal-title":"JAMA - J Am Med Assoc"},{"issue":"33","key":"10.1016\/j.vaccine.2024.06.057_b0085","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.15585\/mmwr.mm7133a3","article-title":"Safety monitoring of Pfizer-BioNTech COVID-19 vaccine booster doses among children aged 5\u201311 Years \u2014 United States, May 17\u2013July 31, 2022","volume":"71","author":"Hause","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.vaccine.2024.06.057_b0090","doi-asserted-by":"crossref","first-page":"E2218505","DOI":"10.1001\/jamanetworkopen.2022.18505","article-title":"Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval among Adolescents and Adults in Ontario, Canada","volume":"5","author":"Buchan","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2024.06.057_b0095","first-page":"1","article-title":"Myocarditis after Covid-19 vaccination in a large health care organization","author":"Witberg","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.06.057_b0100","unstructured":"Canada PHA of. COVID-19 Vaccine: Canadian Immunization Guide.; 2022."},{"key":"10.1016\/j.vaccine.2024.06.057_b0105","unstructured":"Public Health Agency of Canada. COVID-19 vaccination in Canada. Ottawa: Public Health Agency of Canada. https:\/\/health-infobase.canada.ca\/covid-19\/vaccination-coverage\/. Accessed October 11, 2022."},{"key":"10.1016\/j.vaccine.2024.06.057_b0110","article-title":"Canadian paediatricians\u2019 approaches to managing patients with adverse events following immunization: The role of the Special Immunization Clinic network","author":"Top","year":"2014","journal-title":"Paediatr Child Heal"},{"key":"10.1016\/j.vaccine.2024.06.057_b0115","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0000000000001323","article-title":"Immunizing patients with adverse events after immunization and potential contraindications to immunization: A report from the special immunization clinics network","author":"Top","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10.1016\/j.vaccine.2024.06.057_b0120","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.21037\/tp-23-230","article-title":"Chest pain attendances to a Paediatric Emergency Department pre- and post-COVID-19 vaccination","volume":"12","author":"Tan","year":"2023","journal-title":"Transl Pediatr"},{"issue":"7","key":"10.1016\/j.vaccine.2024.06.057_b0125","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1007\/s10875-022-01372-9","article-title":"Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis","volume":"42","author":"Bolze","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.vaccine.2024.06.057_b0130","unstructured":"National Advisory Committee on Immmunization. Rapid response: Updated recommendation on the use of authorized COVID-19 vaccines in individuals aged 12 years and older in the context of myocarditis and pericarditis reported following mRNA COVID-19 vaccines. Public Health Agency of Canada. https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/documents\/services\/immunization\/national-advisory-committee-on-immunization-naci\/rapid-response-recommendation-use-covid-19-vaccines-individuals-aged-12-years-older-myocarditis-pericarditis-reported-following-mr. Published 2022. Accessed October 26, 2022."},{"issue":"September","key":"10.1016\/j.vaccine.2024.06.057_b0135","first-page":"1","article-title":"Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.06.057_b0140","unstructured":"Public Health Agency of Canada. COVID-19 vaccine: Canadian Immunization Guide. Canadian Immunization Guide. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-4-active-vaccines\/page-26-covid-19-vaccine.html. Published 2022. Accessed October 26, 2022."},{"key":"10.1016\/j.vaccine.2024.06.057_b0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.amjcard.2022.02.039","article-title":"Myopericarditis after COVID-19 booster dose vaccination","volume":"172","author":"Sharff","year":"2022","journal-title":"Am J Cardiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2400731X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2400731X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T17:56:52Z","timestamp":1729015012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2400731X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":29,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0264410X2400731X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.057","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short- and long-term outcomes of cardiac adverse events following COVID-19 immunization managed in a Canadian pediatric center","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126090"}}